# Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy

Article · Diego Chowell, Luc G.T. Morris, Claud M. Grigg, Jeffrey K. Weber, Robert M. Samstein, Vladimir Makarov, Fengshen Kuo, Sviatoslav M. Kendall, David Requena, Nadeem Riaz, Benjamin D. Greenbaum, James Carroll, Edward B. Garon, David Michael Hyman, Ahmet Zehir, David B. Solit, Michael F. Berger, Ruhong Zhou, Naiyer A. Rizvi, Timothy An-thy Chan

- Archive id: doi:10.1126/science.aao4572
- Published: 2017-12-07
- Venue: Science
- DOI: https://doi.org/10.1126/science.aao4572
- PMID: 29217585
- Citations: 1,141
- Source URL: https://doi.org/10.1126/science.aao4572
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Cancer Immunotherapy](https://space-kitty.com/topics/cancer-immunotherapy)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.